Legalize / Ireland / Statutory Instrument

S.I. No. 532/2017 - Misuse of Drugs (Amendment) Regulations 2017

Type Statutory Instrument

Publication 2017-12-01

Last updated 2022-05-03

State Repealed superseded text

Text As published

Source Irish Statute Book

articles 3

This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.

1 amending act · 2022-05-03, S.I. No. 210/2022 - Misuse of Drugs (Amendment) Regulations 2022

Reform history JSON API

Notice of the making of this Statutory Instrument was published in

“Iris Oifigiúil” of 1st December, 2017.

I, CATHERINE BYRNE, Minister of State at the Department of Health, in exercise of the powers conferred on me by sections 4, 5 (as amended by section 15 of the Misuse of Drugs Act 1984 (No. 18 of 1984) and section 3 of the Misuse of Drugs (Amendment) Act 2016 (No. 9 of 2016)), 18 and 38 of the Misuse of Drugs Act 1977 (No. 12 of 1977), section 5 of the Misuse of Drugs Act 1984 and the Health (Delegation of Ministerial Functions) (No. 4) Order 2017 ( S.I. No. 339 of 2017 ), hereby make the following regulations:

1.

(1) These Regulations may be cited as the Misuse of Drugs (Amendment) Regulations 2017.

(2) The Principal Regulations and these Regulations may be cited together as the Misuse of Drugs Regulations 2017.

2.

In these Regulations “Principal Regulations” means the Misuse of Drugs Regulations 2017 ( S.I. No. 173 of 2017 ).

3.

Paragraph 1(a) of Schedule 1 to the Principal Regulations is amended—

(a) by inserting “3,4-Dichloro-N-(2-dimethylamino-cyclohexyl)-N-methyl-benzamide (otherwise known as U-47700)” after “3,4-Dichloro-N-[[1-(dimethylamino) cyclohexyl]methyl]benzamide (otherwise known as AH-7921)”,

(b) by inserting “Ethyl phenyl(piperidin-2-yl) acetate (otherwise known as Ethylphenidate)” after “3-Dimethylheptyl-11-hydroxyhexahydrocannabinol”,

(d) by inserting “N-Methyl-1-(thiophen-2-yl) propan-2-amine (otherwise known as Methiopropamine)” after “1-(4-Methylphenyl)-2-methylaminopropan-1-one”.

GIVEN under my Hand,

24 November 2017.

CATHERINE BYRNE,

Minister of State at the Department of Health.

EXPLANATORY NOTE

(This note is not part of the Instrument and does not purport to be a legal interpretation.)

The purpose of these Regulations is to amend the Misuse of Drugs Regulations 2017 by inserting into Schedule 1 to those Regulations the following:

3,4-Dichloro-N-(2-dimethylamino-cyclohexyl)-N-methyl-benzamide (otherwise known as U-47700);

Ethyl phenyl(piperidin-2-yl) acetate (otherwise known as Ethylphenidate);

1-(5-Fluoropentyl)-1H-indol-3-yl methanone (otherwise known as XLR-11); and

N-Methyl-1-(thiophen-2-yl) propan-2-amine (otherwise known as Methiopropamine).

These Regulations may be cited as the Misuse of Drugs (Amendment) Regulations 2017.

This document does not substitute the official text published in the Irish Statute Book. We accept no responsibility for any inaccuracies arising from the transcription of the original into this format.

This text is published under Irish Statute Book's own terms of reuse, not a Legalize or public-domain licence. Irish Statute Book
CC-BY 4.0 (Oireachtas Open Data PSI Licence)
Contains Irish Public Sector Information licensed under the Oireachtas (Houses of the Oireachtas) Open Data PSI Licence / Creative Commons Attribution 4.0 International, sourced from https://www.irishstatutebook.ie.